Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Los Angeles clinic diluted more than 2,000 doses of COVID-19 vaccine

LOS ANGELES — A Los Angeles clinic diluted more than 2,000 doses of the COVID-19 vaccine, and did not inform some patients until months later, according to a report.

Los Angeles Times

3 Stocks to Buy That Won’t Give You Any Headaches

The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

‘Completely new’ COVID strains possible in winter: EU drug agency

Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.

Al Jazeera

From analysis to the latest developments in health,
read the most diverse news in one place.

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

EU regulator gives green light to omicron booster vaccines

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

Radio France Internationale

New omicron COVID-19 boosters are coming. Here’s what you need to know

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

The Denver Post

Denmark expects winter without COVID restrictions - health minister

Denmark is preparing to go through the coming winter without any coronavirus restrictions even with an expected rise in infections, Health Minister Magnus Heunicke said on Friday.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Wales sees another huge drop in its Covid infection rate

Infection rates have not been this low since early June

Wales Online

There's no bad time to get a new COVID booster if you're eligible, CDC director says

People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.

WEKU

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Novak Djokovic’s absence from the US Open has made him a hero to the right

The three-time champion at Flushing Meadows is forbidden from entering the US. Many conservatives have used him to push their agenda

The Guardian - US

CDC recommends updated COVID-19 boosters

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

Axios

CDC advisers endorse booster shots that target omicron for Americans 12 and up

The United States should replace most of its COVID-19 booster shots with updated versions that target the dominant omicron strains, an influential group of vaccine experts that advises the Centers for Disease Control and Prevention said Thursday.

Los Angeles Times

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

CDC advisers back use of updated COVID-19 vaccine boosters - Roll Call

Moderna’s shot will be available to adults 18 and older, and Pfizer’s will be available to individuals 12 and older.

Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

WEKU

CDC recommends new booster shots to fight omicron

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

ABC News

Viral claims are blaming a surge in excess deaths in Europe on vaccines. But experts say that's not the case

A jump in the number of deaths among children in Europe could be caused by numerous factors, experts said, but vaccines are not to blame.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

India-made HPV vaccine to cost ₹200

CERVAVAC, India’s first indigenously developed vaccine to prevent cervical cancer, has been developed by SII

Chicago Sun-Times

Arwady on new COVID shot: Get boosted ASAP

“We very much are going to want people to get this updated vaccine right now and not wait three or four months,” she said.

Reuters

Germany to start Omicron-adapted COVID vaccinations next week - minister

Germany can next week start using COVID-19 vaccines which have been adapted for the Omicron variant and got approval for use in the European Union on Thursday, Health Minister Karl Lauterbach said.

The Independent UK

CDC advisers weigh who needs updated COVID booster and when

Government advisers are debating who should should get new updated COVID-19 boosters and when

Bangkok Post

EU regulator approves Omicron vaccines

The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.

Benzinga

Everest Medicines Descends To New Depths On String Of Bad News

Key Takeaways: The CEO of Everest Medicines resigned two days after the company announced its loss grew sharply in the first half of the year The company also lost an important potential new revenue source after transferring rights for one of its core products to another company By Emily Chan

The Independent UK

Limited funding hampers charities’ early monkeypox response

Two biopharmaceutical companies will give $5 million and $500,000, respectively, to nonprofit organizations in the United States and abroad that are responding to the growing monkeypox outbreak

1 … 190 191 192 193

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Centers for Disease Control and Prevention

314 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.